Serum tumour markers in renal failure

International Urology and Nephrology

Volumn 28, Issue 4, 1996, Pages 601-604

  Arik, N ^a   Adam, B ^a   Akpolat, T ^a   Hasil K ^a   Tabak, S ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY CANCER; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 0030452914     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550974     Document Type: Article

References (17)

1. Matas, A. J., Simmons, R. L., Kjellstrand, C. M., Buselmeir, T. J., Najarian, J. S.: Increased incidence of malignancy during chronic renal failure. Lancet, 1, 883 (1975).
2. Kinlen, L. J., Eastwood, J. B., Kerr, D. N.: Cancer in patients receiving dialysis. Br. Med. J., 1, 1401 (1980).
3. Slifkin, R. F., Goldberg, J., Neff, M. S.: Malignancy in end stage renal disease. Trans. Am. Soc. Artif. Intern. Organs, 23, 34 (1977).
4. Lindler, A., Farewell, V. T., Sherrard, D. J.: High incidence of neoplasia in uremic patients receiving long-term hemodialysis. Nephron, 27, 292 (1981).
5. Bush, A., Gabriel, R.: Cancer in uremic patients. Clin. Nephrol., 22, 77 (1984).
6. Pecquek, J. C., Schwarz, A., Dieckmann, K. D., Offermann, G.: Cancer incidence in patients on chronic dialysis and in renal transplant recipients. Urol. Int., 45, 290 (1990).
7. Kantar, A. F., Hoover, R. N., Kinlen, L. J., Mc Mullan, M. R., Fraumeri, J. F.: Cancer in patients receiving long term dialysis treatment. Am. J. Epidemiol., 126, 370 (1987).
8. Port, F. K., Nawal, E., Raghep, M. P. H., Schwartz, A. G., Hawthorne, V. M.: Neoplasms in dialysis patients: A population-based study. Am. J. Kidney Dis., 2, 119 (1989).
9. Bates, S. E.: Clinical applications of serum tumor markers. Ann. Intern. Med., 115, 623 (1991).
10. Odagiri, E., Jibiki, K., Takedo, M., Sugimura, H., Iwachika, C., Abe, Y., Kihara, K., Kihara, Y., Hov, M., Namura, T., Kuba, K., Sugino, N., Ohta, K., Demura, R., Demura, H.: Effect of hemodialysis on the concentration of the seven tumor markers: Carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients. Am. J. Nephrol., 11, 363 (1991).
11. Zeferos, N., Digenis, G. E., Christophoraki, M., Alexopoulos, I., Kostakis, A., Gyftaki, H., Moulopoulos, S.: Tumor markers in patients undergoing hemodialysis and kidney transplantation. Nephron, 59, 618 (1991).
12. Filello, X., Cases, A., Molino, R., Jo, J., Bedini, J. L., Revert, L., Ballesto, A. M.: Tumor markers in patients with chronic renal failure. Int. J. Biol. Markers, 5(2), 85 (1990).
13. Cases, A., Filello, X., Molino, R., Balesta, A. M., Pedret, J. L., Revert, L.: Tumor markers in chronic renal failure and hemodialysis patients. Nephron, 57, 183 (1991).
14. De Santo, N. G., Venerosa, S.; Capadicaso, G.: Tumor markers in uremia; carcinoembryonic antigen, neuron-specific enolase, carbohydrate antigen CA-50 and alpha-fetoprotein. Am. J. Nephrol., 6, 458 (1986).
15. Ammon, A., Eiffert, H., Weber, M. H.: Tumor markers in dialysis-dependent renal failure: A comparison of the mucin-like carcinoma antigen CA 15.3, CA-125, CA 19.9, and CEA antigens. Oncology, 11, 260 (1988).
16. Inamoto, H., Ozoki, R., Matsuzaki, T., Wakut, M., Saruta, T., Osawa, A.: Incidence and mortality pattern of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron, 59, 611 (1991).
17. Docci, D., Pistocchi, E., Turci, F., Baldrati, L., Urbini, S., Scaioli, S.: Serum CA 19.9 and CA 50 antigens in hemodialysis patients. Clin. Nephrol., 27 (4), 179 (1987).